Cargando…
Correction: Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3
Autores principales: | Huang, Zixian, Zhang, Yin, Li, Haigang, Zhou, Yufeng, Zhang, Qianyu, Chen, Rui, Jin, Tingting, Hu, Kaishun, Li, Shihao, Wang, Yan, Chen, Weiliang, Huang, Zhiquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078203/ https://www.ncbi.nlm.nih.gov/pubmed/32184381 http://dx.doi.org/10.1038/s41419-020-2389-0 |
Ejemplares similares
-
Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3
por: Huang, Zixian, et al.
Publicado: (2019) -
RPS3 Promotes the Metastasis and Cisplatin Resistance of Adenoid Cystic Carcinoma
por: Rui, Xi, et al.
Publicado: (2022) -
GSDMD enhances cisplatin-induced apoptosis by promoting the phosphorylation of eIF2α and activating the ER-stress response
por: Zhang, Qianyu, et al.
Publicado: (2022) -
Silencing LCN2 suppresses oral squamous cell carcinoma progression by reducing EGFR signal activation and recycling
por: Huang, Zixian, et al.
Publicado: (2023) -
Correction: Silencing LCN2 suppresses oral squamous cell carcinoma progression by reducing EGFR signal activation and recycling
por: Huang, Zixian, et al.
Publicado: (2023)